Eli Lilly: I Admit Defeat As I Understated Its Growth Prospects (Upgrade)
Eli Lilly's valuation is a critical concern, but its robust execution has improved its ability to actualize its high-growth ...
FTC sues drug middlemen for allegedly inflating insulin prices
The FTC suit targets the three biggest so-called pharmacy benefit managers, UnitedHealth Group's Optum Rx, CVS Health's ...
US FTC sues drug 'gatekeepers' over high insulin prices
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...
FTC Accuses Drug Middlemen of Inflating Insulin Prices
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms ...
U.S. weight-loss medicine makers cut prices for insurance inclusion: WSJ
Eli Lilly and Novo Nordisk the pharmaceutical heavyweights selling popular weight-loss injections are each dangling discounts to gain an edge and to ...
Feds sue pharmacy gatekeepers over high insulin costs
Insulin, used by millions of Americans, has taken center stage in the high-stakes battle over health care costs. Though ...
Wall Street today: US stocks surge stops as investors pause after big US Fed rate cut, Nike gains 6.59%
The US stock markets opened lower on Friday, September 20, as investors held back after a jump in the previous session, which ...
medtechdive53m
GE Healthcare wins FDA clearance for Alzheimer’s imaging software
GE Healthcare’s Vizamyl is supported, as are Lilly’s Amyvid and Life Molecular Imaging’s Neuraceq. Sales of Vizamyl are currently “a few million dollars,” GE Healthcare CFO James Saccaro said on an ...